Dianthus Therapeutics DNTH
$84.55 −$0.28 (-0.33%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $84.08 -0.56%
Open$83.62
Prev close$84.83
Day range$82.53 – $85.67
Volume799.7K
Market cap$4.76B
P/E (TTM)–
Dividend yield–
DNTH Stock News
Headlines matching Dianthus Therapeutics or the DNTH ticker, most recent first.
- Citi Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $156
- LifeSci Capital Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $125
- J.P. Morgan Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
- William Blair Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
- J.P. Morgan Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $135
- A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $200
- Truist Financial Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $128
- A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $150
- Stifel Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $133
- Evercore Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $134 Positive
- Wells Fargo Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $135
- Jefferies Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $132
- Truist Financial Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
- Wedbush Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $105
- Raymond James Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
No comments yet — be the first to weigh in on DNTH.
Sign in to join the discussion.